MIKART FDA Approval ANDA 040387

ANDA 040387

MIKART

FDA Drug Application

Application #040387

Application Sponsors

ANDA 040387MIKART

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL325MG/15ML;50MG/15ML;40MG/15ML0BUTALBITAL, ACETAMINOPHEN AND CAFFEINEACETAMINOPHEN; BUTALBITAL; CAFFEINE

FDA Submissions

ORIG1AP2003-01-31
LABELING; LabelingSUPPL10AP2009-07-06
LABELING; LabelingSUPPL12AP2011-06-22
LABELING; LabelingSUPPL13AP2013-10-18STANDARD

Submissions Property Types

SUPPL12Null7
SUPPL13Null15

CDER Filings

MIKART
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40387
            [companyName] => MIKART
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","activeIngredients":"ACETAMINOPHEN; BUTALBITAL; CAFFEINE","strength":"325MG\/15ML;50MG\/15ML;40MG\/15ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","submission":"ACETAMINOPHEN; BUTALBITAL; CAFFEINE","actionType":"325MG\/15ML;50MG\/15ML;40MG\/15ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.